Heartseed

  • NEWS
  • PIPELINE
  • TECHNOLOGY
  • ABOUT US
    • CEO Message
    • Purpose
    • Company Profile
    • Management
  • Mission & Values
  • CONTACT
  • JP/EN
  1. HOME
  2. NEWS
  3. 2021

2021

2021323

PRHeartseed Initiates Ph1/2 Clinical Trial of iPSC-derived Cardiomyocyte Spheroids (LAPiS Study) in Japan

202131

PRHeartseed named “Minister of Science and Technology Policy Award”  at Japan Venture Awards 2021

2021128

OtherTaiji Edogawa was appointed as External Audit & Supervisory Board Member

12

COMPANY OVERVIEW

To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the access of RM.

Company name
Heartseed Inc.
Head Office
The Artcomplex Center of Tokyo #302, 12-9, Daikyo-cho, Shinjuku-ku, Tokyo 160-0015, JAPAN
Contact
contact@heartseed.jp

MORE VIEW

MENU

  • Home
  • News
  • PIPELINE
  • TECHNOLOGY
  • About us
  • Mission & Values
  • Contacts

language

  • English
  • Japanese
  • GO TO TOP

Copyright © All Rights Reserved HEARTSEED HEARTSEED